• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞膜包覆的纳米粒子:研究进展。

Cell membrane-coated nanoparticles: research advances.

机构信息

Marine Bio-pharmaceutical Institute, Naval Medical University, Shanghai, 200433, PR China.

出版信息

Nanomedicine (Lond). 2020 Mar;15(6):625-641. doi: 10.2217/nnm-2019-0388. Epub 2020 Feb 26.

DOI:10.2217/nnm-2019-0388
PMID:32098564
Abstract

Cell membranes have been continuously imitated and used for the modification of nanoparticles (NPs) to improve NP biological properties. Cell membrane-coated NPs, where core NPs are wrapped with plasma membrane vesicles, show high biocompatibility, targeting specificity and low side effects. Compared with conventional strategies, this novel approach directly leverages intact and natural functions of cell membranes, instead of replicating these features via synthetic techniques. This top-down technique bestows NPs with enhanced biointerfacing capabilities with potential in the diagnosis and treatment of cancer, infection and other diseases. Herein, we report on the advances in cell membrane-coated NPs, including the preparation process, source cell membranes for wrapping and potential applications of these cell membrane-coated NPs.

摘要

细胞膜不断被模仿并用于修饰纳米颗粒(NPs)以改善 NP 的生物学特性。细胞膜包覆的 NPs 是指核心 NPs 被质膜囊泡包裹,具有高生物相容性、靶向特异性和低副作用。与传统策略相比,这种新方法直接利用细胞膜的完整和天然功能,而不是通过合成技术复制这些特性。这种自上而下的技术赋予 NPs 增强的生物界面功能,在癌症、感染和其他疾病的诊断和治疗方面具有潜在应用价值。本文报告了细胞膜包覆 NPs 的进展,包括制备过程、用于包裹的源细胞膜以及这些细胞膜包覆 NPs 的潜在应用。

相似文献

1
Cell membrane-coated nanoparticles: research advances.细胞膜包覆的纳米粒子:研究进展。
Nanomedicine (Lond). 2020 Mar;15(6):625-641. doi: 10.2217/nnm-2019-0388. Epub 2020 Feb 26.
2
White Blood Cell Membrane-Coated Nanoparticles: Recent Development and Medical Applications.白细胞膜包覆纳米粒子:最新进展与医学应用。
Adv Healthc Mater. 2022 Apr;11(7):e2101349. doi: 10.1002/adhm.202101349. Epub 2021 Aug 31.
3
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.混合细胞膜包覆纳米颗粒:用于癌症诊断与治疗的多功能仿生平台。
Acta Biomater. 2020 Aug;112:1-13. doi: 10.1016/j.actbio.2020.05.028. Epub 2020 May 26.
4
Surface modification potentials of cell membrane-based materials for targeted therapies: a chemotherapy-focused review.细胞膜基材料的靶向治疗表面修饰潜力:以化疗为重点的综述。
Nanomedicine (Lond). 2023 Aug;18(19):1281-1303. doi: 10.2217/nnm-2023-0164. Epub 2023 Sep 27.
5
Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting.微流控超声处理组装外泌体膜包覆的纳米颗粒用于免疫逃逸介导的靶向。
Nano Lett. 2019 Nov 13;19(11):7836-7844. doi: 10.1021/acs.nanolett.9b02841. Epub 2019 Oct 11.
6
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles.细胞膜包覆纳米粒子的生物界面与应用
Bioconjug Chem. 2017 Jan 18;28(1):23-32. doi: 10.1021/acs.bioconjchem.6b00569. Epub 2016 Nov 16.
7
Advances in cell membrane-coated nanoparticles and their applications for bone therapy.细胞膜包覆纳米粒子的研究进展及其在骨治疗中的应用。
Biomater Adv. 2023 Jan;144:213232. doi: 10.1016/j.bioadv.2022.213232. Epub 2022 Dec 5.
8
Cancer Cell Membrane-Coated Nanoparticles for Cancer Management.用于癌症治疗的癌细胞膜包被纳米颗粒
Cancers (Basel). 2019 Nov 21;11(12):1836. doi: 10.3390/cancers11121836.
9
"Nanodecoys" - Future of drug delivery by encapsulating nanoparticles in natural cell membranes."纳米诱饵" - 通过将纳米粒子封装在天然细胞膜中来实现药物输送的未来。
Int J Pharm. 2022 Jun 10;621:121790. doi: 10.1016/j.ijpharm.2022.121790. Epub 2022 May 2.
10
Cell membrane coated nanoparticles: next-generation therapeutics.细胞膜包覆的纳米颗粒:新一代治疗方法。
Nanomedicine (Lond). 2017 Nov;12(21):2677-2692. doi: 10.2217/nnm-2017-0225. Epub 2017 Oct 2.

引用本文的文献

1
Biomembrane-coated nanosystems as next-generation delivery systems for the treatment of gastrointestinal cancers.生物膜包被的纳米系统作为治疗胃肠道癌症的下一代递送系统。
Bioeng Transl Med. 2025 Feb 26;10(4):e70006. doi: 10.1002/btm2.70006. eCollection 2025 Jul.
2
Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases.仿生细胞膜包覆纳米载体在心血管疾病中的应用
Int J Nanomedicine. 2025 Jun 26;20:8249-8289. doi: 10.2147/IJN.S531558. eCollection 2025.
3
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape.
临床视角下的纳米颗粒疗法:分类、上市产品及监管格局
Small. 2025 Jun 2:e2502315. doi: 10.1002/smll.202502315.
4
Lung Epithelial Cell Membrane-Camouflaged ROS-Activatable Berberine Nanoparticles for Targeted Treatment in Acute Lung Injury.用于急性肺损伤靶向治疗的肺上皮细胞膜伪装的活性氧激活型黄连素纳米颗粒
Int J Nanomedicine. 2025 May 15;20:6163-6183. doi: 10.2147/IJN.S514611. eCollection 2025.
5
The advancement of nanosystems for drug delivery in the prevention and treatment of dental caries.用于预防和治疗龋齿的药物递送纳米系统的进展。
Front Cell Infect Microbiol. 2025 Feb 11;15:1546816. doi: 10.3389/fcimb.2025.1546816. eCollection 2025.
6
Microfluidics-Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle-Vesicle Hybrids.微流控驱动的纳米颗粒-囊泡杂化物的制造及多尺度分析表征
Adv Healthc Mater. 2025 Feb;14(4):e2403264. doi: 10.1002/adhm.202403264. Epub 2024 Dec 25.
7
4T1 Cell Membrane-Coated Pdots with NIR-II Absorption and Fluorescence Properties for Targeted Phototheranostics of Breast Tumors.具有近红外二区吸收和荧光特性的4T1细胞膜包覆钯点用于乳腺肿瘤的靶向光热诊疗
ACS Appl Mater Interfaces. 2024 Dec 4;16(48):66425-66435. doi: 10.1021/acsami.4c12845. Epub 2024 Nov 21.
8
Blood Cell Membrane-Coated Nanomaterials as a Versatile Biomimetic Nanoplatform for Antitumor Applications.血细胞膜包被的纳米材料作为一种用于抗肿瘤应用的多功能仿生纳米平台
Nanomaterials (Basel). 2024 Oct 31;14(21):1757. doi: 10.3390/nano14211757.
9
Biomimetic ROS-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis.负载甲氨蝶呤的仿生活性氧响应性透明质酸纳米颗粒用于靶向抗动脉粥样硬化
Regen Biomater. 2024 Aug 20;11:rbae102. doi: 10.1093/rb/rbae102. eCollection 2024.
10
Lipid-based nanosystems: the next generation of cancer immune therapy.基于脂质的纳米系统:下一代癌症免疫治疗。
J Hematol Oncol. 2024 Jul 19;17(1):53. doi: 10.1186/s13045-024-01574-1.